Board of Directors
PIA-PR 2025-2026 Board of Directors
PIA’s Board of Directors is composed of ten members represented by the company’s top executive in Puerto Rico. Five members represent the manufacturing sector and five the commercial sector. In addition, there are three ex-officio members: The Operations Lead, the legal Counsel, and the Advisor to the Board.
The Executive Committee of the board is composed by:
Executive Committee
David L. Thompson
Chairperson
Site Head
AbbVie
Glorimar Torres
Vice Chairperson
General Manager
Amgen
Commercial Operations
Brandon P. Paschal
Treasurer
SVP Global Dry Products Operations, President & GM
Lilly del Caribe
Javier F. Deida
Secretary
Regional Business Director and Country Lead
Pfizer Biopharmaceutical
Directors
José Castellote
General Manager
J&J Innovative Medicine
Sara M. Miranda
President & General Manager
AstraZeneca Operations/IPR Pharmaceuticals
Iramis Ralat
Executive Director & General Manager
Bristol Myers Squibb
María M. Rivera
Business Director Puerto Rico Market
Organon
Thomas Seewoester
VP Site Operations
Amgen Manufacturing Limited
Alfredo Alonso
General Manager
AstraZeneca
Commercial Operations
Past Presidents
Juan Diddi
General Manager
Bristol Myers Squibb
Ileana Quiñones
VP & General Manager
J&J Innovative Medicines Supply
Ad Hoc Members
José Juan Marrero
Operations Lead
Iván Román
Advisor to the Board
Eduardo Negrón Navas
Legal Counsel